HCID 10417675, compound → HCID 57848519, compound
Reaction equation
[NH2:1][C:2]1[C:45]([C:46]([F:49])([F:48])[F:47])=[CH:44][C:5]([CH2:6][C@@H:7]([CH2:23][C:24]([N:26]2[CH2:31][CH2:30][CH:29]([N:32]3[CH2:38][CH2:37][C:36]4[CH:39]=[CH:40][CH:41]=[CH:42][C:35]=4[NH:34][C:33]3=[O:43])[CH2:28][CH2:27]2)=[O:25])[C:8]([N:10]2[CH2:15][CH2:14][CH:13]([N:16]3[CH2:21][CH2:20][N:19]([CH3:22])[CH2:18][CH2:17]3)[CH2:12][CH2:11]2)=[O:9])=[CH:4][C:3]=1Br>CO.[Pd]>[NH2:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][C@@H:7]([CH2:23][C:24]([N:26]2[CH2:27][CH2:28][CH:29]([N:32]3[CH2:38][CH2:37][C:36]4[CH:39]=[CH:40][CH:41]=[CH:42][C:35]=4[NH:34][C:33]3=[O:43])[CH2:30][CH2:31]2)=[O:25])[C:8]([N:10]2[CH2:15][CH2:14][CH:13]([N:16]3[CH2:17][CH2:18][N:19]([CH3:22])[CH2:20][CH2:21]3)[CH2:12][CH2:11]2)=[O:9])=[CH:44][C:45]=1[C:46]([F:49])([F:48])[F:47]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
100 mg 10% Pd/C were added to a solution of 150 mg (0.2 mmol) (S)-2-(4-amino-3-bromo-5-trifluoromethyl-benzyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dione in 20 mL MeOH and the reaction mixture was hydrogenated at 50 psi H2 for 3 h at RT. The catalyst was suction filtered, the solvent was evaporated down i.vac., the residue was combined with 5% K2CO3 solution and EtOAc, the organic phase was separated off and evaporated down i.vac. The residue was triturated with diisopropylether and suction filtered.
Workup
- filtrationfiltered
- customthe solvent was evaporated down i.vac
- customthe organic phase was separated off
- customevaporated down i.vac
- customThe residue was triturated with diisopropylether and suction
- filtrationfiltered
Sources & evidence
- ORD record
- ord-5f5acc42f407473dacf1bab9a171293a
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07595312B2
Reaction notes
Loading…